Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies

Adv Sci (Weinh). 2022 Apr;9(11):e2104495. doi: 10.1002/advs.202104495. Epub 2022 Jan 17.

Abstract

COVID-19 vaccines have constituted a substantial scientific leap in countering severe acute respiratory syndrome type 2-causing coronavirus (SARS-CoV-2), and worldwide implementation of vaccination programs has significantly contributed to the global pandemic effort by saving many lives. However, the continuous evolution of the SARS-CoV-2 viral genome has resulted in different variants with a diverse range of mutations, some with enhanced virulence compared with previous lineages. Such variants are still a great concern as they have the potential to reduce vaccine efficacy and increase the viral transmission rate. This review summarizes the significant variants of SARS-CoV-2 encountered to date (December 2021) and discusses a spectrum of possible preventive strategies, with an emphasis on physical and materials science.

Keywords: COVID-19; prevention; severe acute respiratory syndrome type 2-causing coronavirus; spike protein mutations; variant of concern.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Mutation
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2